Mrs. Kelsey E Williams, Surgery Medicare: Accepting Medicare Assignments Practice Location: 844 Battlefield Blvd N Ste 100, Chesapeake, VA 23320 Phone: 757-312-3033 Fax: 757-842-4490 |
Dr. Marc Kamel Boustany, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Volvo Pkwy Ste 210, Chesapeake, VA 23320 Phone: 757-261-5000 Fax: 757-962-5610 |
Dr. Meghan Annette Whitlatch, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq Ste 400, Chesapeake, VA 23320 Phone: 757-842-4499 |
Dr. Adam J. Meyers, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq Ste 400, Chesapeake, VA 23320 Phone: 757-842-4499 |
Dr. Ahmed A Rahman, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq Ste 400, Chesapeake, VA 23320 Phone: 757-842-4499 Fax: 757-842-4490 |
John Kabzeel Yesudas Chacko, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3212 Churchland Boulevard, Suite 8, Chesapeake, VA 23321 Phone: 757-399-0886 Fax: 757-399-1191 |
Dr. Ivor Purchas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2537 Lakewood Ln, Chesapeake, VA 23321 Phone: 757-488-5730 |
News Archive
InfoLogix, Inc., a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, and CareTrends Systems, a leading vital sign integration and intelligence software company, today announced a strategic partnership to help deliver advanced patient care and decrease costs for hospitals across North America.
Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes-and revealing new clues as to what happens when this process goes awry.
Health ministers from countries worldwide next week at the World Health Assembly will discuss issues surrounding patents and access to drugs for diseases such as HIV/AIDS in developing countries, Reuters UK reports.
Boston Scientific Corporation (NYSE: BSX) today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS((R)) Express(2)(TM) Paclitaxel-Eluting Coronary Stent System and the XIENCE V(TM) (PROMUS((R))) Everolimus-Eluting Coronary Stent System.
Dr Choong-Siew Yong, Psychiatrist and Chair of the AMA's Public Health and Ethics Committee, today welcomed Labor's commitment to focus on mental health as a national health priority
› Verified 9 days ago